Skip to main content
. 2013 Apr 27;5(4):206–213. doi: 10.4254/wjh.v5.i4.206

Figure 1.

Figure 1

Immunohistochemical detection of hepatic apurinic/apyrimidinic endonuclease 1 protein in patients with chronic liver disease. The intensity of hepatocytic nuclear apurinic/apyrimidinic endonuclease 1 immunoreactivity was classified into four grades.